Security record · archived quarter
ALC
Alcon Inc. · Healthcare · Medical - Specialties
12Tracked holders
—Δ holders
18.62MShares held
$1.66BReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 127 | 0 | 163.73M | $10.99B | +8 | −7 |
| Q1 2026 | 128 | -2 | 149.67M | $11.22B | +4 | −7 |
| Q4 2025 | 130 | +1 | 168.20M | $13.30B | +2 | — |
| Q3 2025 | 18 | +1 | 56.88M | $4.25B | +3 | −3 |
| Q2 2025 | 15 | -4 | 57.20M | $5.06B | — | −4 |
| Q1 2025 | 16 | +1 | 22.35M | $2.11B | +1 | — |
| Q4 2024 | 15 | +2 | 21.30M | $1.81B | +3 | −1 |
| Q3 2024 | 12 | 0 | 17.31M | $1.73B | +2 | −2 |
| Q2 2024 | 12 | — | 18.62M | $1.66B | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Norges Bank ✦ (passive) | 12.35M | — | $1.10B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Marshall Wace ✦ | 3.04M | — | $271.18M | 0.4% | n/c | 1 | SEC ↗ |
| 3 | Marshall Wace ✦ | 3.04M | — | $271.18M | 0.4% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 1.45M | — | $128.80M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.45M | — | $128.80M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 791.45K | — | $70.50M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 289.61K | — | $25.80M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 289.61K | — | $25.80M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 268.25K | — | $23.95M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 268.25K | — | $23.95M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 268.25K | — | $23.95M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 268.25K | — | $23.95M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 247.66K | — | $22.06M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 115.87K | — | $10.32M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 56.29K | — | $5.01M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 56.29K | — | $5.01M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 8.09K | — | $720,657 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 8.01K | — | $713,085 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 3.33K | — | $296,547 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2 holders, 868.08K shares, $64.02M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API